Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Novus Therapeutics Inc (NVUS)

Novus Therapeutics Inc (NVUS)
14.60 -0.80 (-5.19%) 01/05/21 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Mon, Jan 4th, 2021
Day Low
14.60
Day High
15.77
Open 15.60
Previous Close 15.40 15.40
Volume 87,000 87,000
Avg Vol 32,005 32,005
Stochastic %K 22.06% 22.06%
Weighted Alpha -62.20 -62.20
5-Day Change +0.79 (+5.72%) +0.79 (+5.72%)
52-Week Range 4.50 - 27.32 4.50 - 27.32
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,970
  • Shares Outstanding, K 1,436
  • Annual Sales, $ 0 K
  • Annual Income, $ -16,010 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.73
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -15.06
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/16/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -3.60
  • Number of Estimates 1
  • High Estimate -3.60
  • Low Estimate -3.60
  • Prior Year -3.24
  • Growth Rate Est. (year over year) -11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.61 +7.27%
on 12/28/20
Period Open: 22.14
23.99 -39.14%
on 12/10/20
-7.54 (-34.06%)
since 12/04/20
3-Month
13.61 +7.27%
on 12/28/20
Period Open: 16.20
27.32 -46.56%
on 10/30/20
-1.60 (-9.88%)
since 10/02/20
52-Week
4.50 +224.44%
on 03/20/20
Period Open: 10.98
27.32 -46.56%
on 10/30/20
+3.62 (+32.97%)
since 01/03/20

Business Summary

Novus Therapeutics, Inc. is a pharmaceutical company. It focused on the acquisition, development and commercialization of ear, nose and throat products. The company's platform consists of OP-01 Foam Platform and OP-02 Surfactant Program. Novus Therapeutics, Inc., formerly known as Tokai Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 16.16
1st Resistance Point 15.38
Last Price 14.60
1st Support Level 14.21
2nd Support Level 13.82
3rd Support Level N/A

See More

52-Week High 27.32
Fibonacci 61.8% 18.60
Fibonacci 50% 15.91
Last Price 14.60
Fibonacci 38.2% 13.22
52-Week Low 4.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar